Indefinite Delivery Contract W81XWH22D0016
- Not listed
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded this multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide preclinical development support for candidate products and drug development activities related to HIV, hepatitis B, hepatitis C, and tuberculosis. The $107.3 million contract has a 7-year period of performance and encompasses seven task areas, including in vitro testing, synthesis of...
- The Defense Health Agency awarded a single-award Blanket Purchase Agreement valued at $5.3 million to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) effective September 22, 2022, through September 27, 2027. This indefinite delivery vehicle authorizes the Defense Health Agency to issue firm-fixed-price delivery orders for custom DNA reagents, MYBAITS reagents, sequencing kits, and related genomic products manufactured by Biodiscovery at its facility in Ann Arbor, Michigan. No small...
- The provided information describes a single-award Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The prime contractor, Aapharmasyn LLC (a small disadvantaged business), will provide Experimental Therapeutics Medicinal Chemistry services with a contract ceiling of $50,000,000 and a period of performance through September 14, 2032. The contract primarily supports...
- The National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to Alchem Laboratories Corporation. The contract has a potential value of $7,777,665 and a period of performance from September 2017 to September 2022. Under the contract, Alchem Laboratories Corporation provides non-good manufacturing practices synthesis of small molecules to support the National Cancer Institute's...
- The Department of Health and Human Services National Institutes of Health (NIH) awarded an Indefinite Delivery Contract (IDC) to Alchem Laboratories Corporation, doing business as Alchem Laboratories Corp, to provide drug formulation and manufacturing services. The $45,000,250 multiple-award IDC was partially set aside for small businesses and has a period of performance through September 2024. Under this IDC, Alchem Laboratories has been issued task orders to synthesize non-GMP small molecule...
- This indefinite delivery contract was awarded by the Department of the Army Medical Command to Eagle Applied Sciences, LLC, a minority-owned small business, as a multiple-award contract under the competitive 8(a) set-aside program. The contract established a potential value of $249 million for research and development support services to be ordered on an as-needed basis by the U.S. Army Medical Research Institute of Infectious Diseases from November 2015 to May 2021. Two task orders have been...
- The Department of the Army Medical Command awarded a multiple award Indefinite Delivery Contract to Tconnex Inc. with a potential value of $249 million. The contract supports the USAMRIID Research and Development program through the delivery of firm-fixed price support services. One task order issued against this contract was for clinical research associate support services at Madigan Hospital in Washington. Valued at $94,928, this firm-fixed price delivery order had a completion date of May...
- This indefinite delivery contract was awarded by the Defense Health Agency, a defense agency, to Credence Management Solutions LLC, a minority-owned small disadvantaged business. The $2,500 delivery order contract is for military medical research and development services. The broader OMNIBUS IV IDIQ contract, under which this task order was issued, is designed to enhance the medical research and development programs of the Department of Defense. It covers a broad range of health-related...
- This indefinite delivery contract (IDC) was awarded by the Joint Program Executive Office for Chemical and Biological Defense (Joint PEO CBD), a defense agency, to Meso Scale Diagnostics LLC, a for-profit limited liability company and Native American-owned small business. The objective of this $8.7 million single-award IDC is to manufacture biodefense assay kits and performance qualification (PQ) kits in support of the U.S. Joint Military Service, Department of Defense, and Department of...
- This indefinite delivery contract (IDC) was awarded by the U.S. Army Medical Command (MEDCOM) to Chesapeake Perl, Inc., a for-profit organization and manufacturer of goods, to provide requirements for proteins. The single-award IDC has a ceiling value of $2,500,000 and a period of performance from December 2011 to December 2014. The task orders issued under this contract cover the development and delivery of various proteins, including an acetylcholinesterase (ACHE) null mutant, over the base...
- W81XWH22D0016Indefinite Delivery Contract
- 2Federal Contract Awards
The Defense Health Agency awarded Creagen Inc., an SBA-certified 8(a) small business, a $1,204,980 single-award Indefinite Delivery Contract (IDC) to provide small molecule synthesis services in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) infectious disease research program. The IDC allows for the synthesis of 350-450 novel small molecule inhibitor analogs, including nucleoside analogs, over a 5-year ordering period. Under this contract, Creagen Inc. has received two delivery orders to date, valued at $68,217.60 and $37,209.60 respectively, for small molecule synthesis tasks in support of USAMRIID's infectious disease countermeasure research. The work is to be performed at Creagen's facility in Woburn, Massachusetts. As a minority-owned small business specializing in chemistry-based drug discovery and development, Creagen provides sophisticated scientific research and synthesis services to multiple federal health and medical research institutions, including the NIH, NIAID, and CDC, in addition to the Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Supplemental Agreement for work within scope | $0 | 6/17/25 | |
| P00002 | Other Administrative Action | $0 | 3/28/24 | |
| P00001 | Other Administrative Action | $0 | 2/9/23 | |
| Not listed | Not listed | $0 | 9/21/22 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order W81XWH22D0016-HT942523F0015 | Creagen Inc. | $37.2k | 11/18/22 | 5/12/23 | 4/4/23 | |
Delivery Order W81XWH22D0016-HT942523F0157 | Creagen Inc. | $68.2k | 6/5/23 | 11/30/23 | 6/5/23 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Small Molecule Synthesis in support of the U. S. Army Medical Research Institute of Infectious Diseases (USAMRIID) | W81XWH22R0084 | Department of the Army Medical Command | Solicitation 1/2 | 8/8/22, 11:42 AM | |
Small Molecule Synthesis in support of the U. S. Army Medical Research Institute of Infectious Diseases (USAMRIID) | W81XWH22D0016 | Department of the Army Medical Command | Award Notice 2/2 | 9/21/22, 11:29 AM |